These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

865 related articles for article (PubMed ID: 26536459)

  • 1. Integrated Analysis of Thyroid Cancer Public Datasets Reveals Role of Post-Transcriptional Regulation on Tumor Progression by Targeting of Immune System Mediators.
    Geraldo MV; Kimura ET
    PLoS One; 2015; 10(11):e0141726. PubMed ID: 26536459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of key genes and miRNAs markers of papillary thyroid cancer.
    Qiu J; Zhang W; Zang C; Liu X; Liu F; Ge R; Sun Y; Xia Q
    Biol Res; 2018 Nov; 51(1):45. PubMed ID: 30414611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of 14q32-encoded miRNAs and tumor suppressor role for miR-654-3p in papillary thyroid cancer.
    Geraldo MV; Nakaya HI; Kimura ET
    Oncotarget; 2017 Feb; 8(6):9597-9607. PubMed ID: 28030816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ret/PTC 1 rearrangement on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model.
    Cahill S; Smyth P; Finn SP; Denning K; Flavin R; O'Regan EM; Li J; Potratz A; Guenther SM; Henfrey R; O'Leary JJ; Sheils O
    Mol Cancer; 2006 Dec; 5():70. PubMed ID: 17156473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.
    Yang Z; Yuan Z; Fan Y; Deng X; Zheng Q
    Mol Med Rep; 2013 Nov; 8(5):1353-8. PubMed ID: 24064622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis.
    Zhang C; Bo C; Guo L; Yu P; Miao S; Gu X
    World J Surg Oncol; 2019 Dec; 17(1):221. PubMed ID: 31842912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of deregulated miRNAs is helpful to distinguish poorly differentiated thyroid carcinoma from papillary thyroid carcinoma.
    Schwertheim S; Sheu SY; Worm K; Grabellus F; Schmid KW
    Horm Metab Res; 2009 Jun; 41(6):475-81. PubMed ID: 19370508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and investigation of lncRNA-associated ceRNA regulatory network in papillary thyroid cancer.
    Zhao Y; Wang H; Wu C; Yan M; Wu H; Wang J; Yang X; Shao Q
    Oncol Rep; 2018 Mar; 39(3):1197-1206. PubMed ID: 29328463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of BRAFV600E mutation on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model.
    Cahill S; Smyth P; Denning K; Flavin R; Li J; Potratz A; Guenther SM; Henfrey R; O'Leary JJ; Sheils O
    Mol Cancer; 2007 Mar; 6():21. PubMed ID: 17355635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum-based six-miRNA signature as a potential marker for EC diagnosis: Comparison with TCGA miRNAseq dataset and identification of miRNA-mRNA target pairs by integrated analysis of TCGA miRNAseq and RNAseq datasets.
    Sharma P; Saraya A; Sharma R
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e289-e301. PubMed ID: 29380534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma.
    Minna E; Romeo P; Dugo M; De Cecco L; Todoerti K; Pilotti S; Perrone F; Seregni E; Agnelli L; Neri A; Greco A; Borrello MG
    Oncotarget; 2016 Mar; 7(11):12731-47. PubMed ID: 26871295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geographical mapping of a multifocal thyroid tumour using genetic alteration analysis & miRNA profiling.
    Aherne ST; Smyth PC; Flavin RJ; Russell SM; Denning KM; Li JH; Guenther SM; O'Leary JJ; Sheils OM
    Mol Cancer; 2008 Dec; 7():89. PubMed ID: 19055826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-mediated networks underlie immune response regulation in papillary thyroid carcinoma.
    Huang CT; Oyang YJ; Huang HC; Juan HF
    Sci Rep; 2014 Sep; 4():6495. PubMed ID: 25263162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA expression in anaplastic thyroid carcinomas.
    Hébrant A; Floor S; Saiselet M; Antoniou A; Desbuleux A; Snyers B; La C; de Saint Aubain N; Leteurtre E; Andry G; Maenhaut C
    PLoS One; 2014; 9(8):e103871. PubMed ID: 25153510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of lncRNA-miRNA-mRNA interactions identified a novel biomarker LINC00657 to improve prognosis prediction of papillary thyroid carcinoma.
    Li S; Wang M; Liu B; Lv Y; Man J; Liang M; Qiao H
    Int Immunopharmacol; 2024 Aug; 137():112432. PubMed ID: 38865751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatics analyses of significant prognostic risk markers for thyroid papillary carcinoma.
    Min XS; Huang P; Liu X; Dong C; Jiang XL; Yuan ZT; Mao LF; Chang S
    Tumour Biol; 2015 Sep; 36(10):7457-63. PubMed ID: 25908172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated analysis of transcription factor-mRNA-miRNA regulatory network related to immune characteristics in medullary thyroid carcinoma.
    Weng D; He L; Chen X; Lin H; Ji D; Lu S; Ao L; Wang S
    Front Immunol; 2022; 13():1055412. PubMed ID: 36713370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA signature predicts survival in papillary thyroid carcinoma.
    Chengfeng X; Gengming C; Junjia Z; Yunxia L
    J Cell Biochem; 2019 Oct; 120(10):17050-17058. PubMed ID: 31099134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncoding RNAs in Papillary Thyroid Cancer: Interaction with Cancer-Associated Fibroblasts (CAFs) in the Tumor Microenvironment (TME) and Regulators of Differentiation and Lymph Node Metastasis.
    Dadafarin S; Carnazza M; Islam HK; Moscatello A; Tiwari RK; Geliebter J
    Adv Exp Med Biol; 2021; 1350():145-155. PubMed ID: 34888848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profiles of microRNAs and their target genes in papillary thyroid carcinoma.
    Liu X; He M; Hou Y; Liang B; Zhao L; Ma S; Yu Y; Liu X
    Oncol Rep; 2013 Apr; 29(4):1415-20. PubMed ID: 23380809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.